Question 1

How many shares of KNTE does MARSHALL WACE, LLP own?

Accepted Answer

MARSHALL WACE, LLP previously held 0 shares of KNTE (KINNATE BIOPHARMA INC) before exiting the position in 2024-Q2.

Question 2

What is MARSHALL WACE, LLP's KNTE position worth?

Accepted Answer

MARSHALL WACE, LLP's KNTE position was last reported at $0 in 2024-Q2 before the exit.

Question 3

Is MARSHALL WACE, LLP buying or selling KNTE?

Accepted Answer

In 2024-Q2, MARSHALL WACE, LLP exited their KNTE position entirely (-100.0% change in shares).

Question 4

When did MARSHALL WACE, LLP first buy KNTE?

Accepted Answer

Based on available 13F filings, MARSHALL WACE, LLP first reported a position in KNTE in 2022-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Decreased	156,089	-19.7%	$415,197	0.0%	—	0
2023-Q4	Increased	194,468	+131.1%	$460,890	0.0%	—	39
2023-Q3	Decreased	84,148	-22.4%	$117,806	0.0%	—	0
2023-Q2	New	108,450	-	$328,604	0.0%	—	33
2023-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q4	Increased	14,944	+30.5%	$91,158	0.0%	—	27
2022-Q3	New	11,452	-	$137,000	0.0%	—	31

KNTE8 quarters

KNTE
8 quarters